WuXi Biologics (Cayman), Inc. (WXIBF)
5.38
-0.94
(-14.87%)
USD |
OTCM |
Oct 26, 16:00
WuXi Biologics Price : 5.38 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 5.52 | 6.19 | 5.38 | 5.38 | 1580.00 |
| Oct 23, 2026 | 5.544 | 6.32 | 5.544 | 6.32 | 5185.00 |
| Oct 22, 2026 | 5.50 | 5.50 | 5.34 | 5.34 | 470.00 |
| Oct 21, 2026 | 6.21 | 6.77 | 6.05 | 6.77 | 1396.00 |
| Oct 20, 2026 | 6.36 | 6.36 | 6.36 | 6.36 | 1143.00 |
| Oct 19, 2026 | 6.36 | 6.36 | 6.36 | 6.36 | 84.00 |
| Oct 16, 2026 | 6.36 | 6.36 | 6.36 | 6.36 | 386.00 |
| Oct 15, 2026 | 6.66 | 6.66 | 5.87 | 6.195 | 3828.00 |
| Oct 14, 2026 | 5.98 | 6.58 | 5.98 | 6.28 | 1296.00 |
| Oct 13, 2026 | 6.19 | 6.84 | 6.19 | 6.52 | 967.00 |
| Oct 12, 2026 | 6.75 | 6.75 | 6.75 | 6.75 | 2605.00 |
| Oct 09, 2026 | 7.13 | 7.29 | 7.13 | 7.29 | 751.00 |
| Oct 08, 2026 | 7.05 | 7.17 | 7.04 | 7.17 | 165586.0 |
| Oct 07, 2026 | 7.49 | 7.49 | 7.20 | 7.49 | 5659.00 |
| Oct 06, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 342.00 |
| Oct 05, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 109.00 |
| Oct 02, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 246.00 |
| Oct 01, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 0.000 |
| Sep 30, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 346.00 |
| Sep 29, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 340.00 |
| Sep 28, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 332.00 |
| Sep 25, 2026 | 6.74 | 6.77 | 6.74 | 6.77 | 10805.00 |
| Sep 24, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 263.00 |
| Sep 23, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 92.00 |
| Sep 22, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 93.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Austar Lifesciences Ltd. | 0.02 |
| Agilent Technologies, Inc. | 175.96 |
| Bio-Rad Laboratories, Inc. | 372.43 |
| Bruker Corp. | 58.23 |
| Azenta, Inc. | 37.17 |
Price Related Metrics
| PE Ratio | 31.55 |
| PS Ratio | 6.646 |
| PEG Ratio | 0.3014 |
| Price to Free Cash Flow | 35.70 |
| Earnings Yield | 3.17% |
| Market Cap | 22.09B |
| PEGY Ratio | 0.3014 |
| Operating PE Ratio | 20.53 |
| Normalized PE Ratio | 33.60 |